Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
DALTEPARIN bulk supplier for pharma manufacturers

Dalteparin 10000 IU Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10000 IU

Reference Brands: Fragmin (US/EU)

Category: Respiratory Disorder

Injection is an anticoagulant medication containing the active constituent dalteparin. It prevents the formation of blood clots by thinning the blood. It is used in the treatment of a condition called venous thromboembolism, where blood clots develop in the lungs (pulmonary embolism) or the legs (deep vein thrombosis) after surgery, in bedridden patients, or in patients with certain types of cancer.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Dalteparin? List it or send an offer →

Product Description: Injection, talk to your doctor if you have an active ulcer, bleeding disorders, liver failure, hemophilia, injury to an operation involving head, spine, eye or ears, septic endocarditis (infection in heart) and condition called heparin-induced thrombocytopenia (decrease in the number of platelets caused by heparin). Inform your doctor if you have uncontrolled blood pressure, and diabetes.

Dalteparin — third party manufacturing & bulk supply

Dalteparin 10000 IU is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Dalteparin is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Dalteparin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Dalteparin →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

DALTEPARIN is listed as Injection in 10000 IU. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

DALTEPARIN is referenced against Fragmin (US/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Poractant ALFA

Strength:
120 mg

Form: Injection

Reference Brands:

View Details
Beractant

Strength:
200 mg

Form: Injection

Reference Brands: Survanta (US)

View Details
Beractant

Strength:
100 mg

Form: Injection

Reference Brands: Survanta (US)

View Details
Glycopyrrolate,Indacaterol

Strength:
110/50 MCG

Form: Inhaler

Reference Brands: Ultibro Breezhaler (EU)

View Details
Beclomethasone Dipropionate

Strength:
40 mcg/inhalation, 80 mcg/inhalation

Form: inhaler/ spray

Reference Brands: QVAR RediHaler®(US); Clenil Modulite®(EU)

View Details
Isoniazid Tablet

Strength:
100 mg, 300 mg

Form: Tablet

Reference Brands: Nydrazid®(US); Rimifon® (Germany)

View Details
Ethofylline & Theophylline Injection

Strength:
84.7 mg Ethofylline + 25.3 mg Theophylline

Form: Injection

Reference Brands: Deriphyllin®

View Details
Doxofylline Tablet

Strength:
200 mg, 400 mg

Form: Tablet

Reference Brands: -

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us